Navigation Links
New Analyses of Data From RE-LY Trial, Involving Oral Anticoagulant Pradaxa, to be Presented at American Heart Association's Scientific Sessions
Date:11/11/2010

dabigatran exposure and should generally be avoided. P-gp inhibitors ketoconazole, verapamil, amiodarone, quinidine, and clarithromycin, do not require dose adjustments. These results should not be extrapolated to other P-gp inhibitors.

ADVERSE REACTIONS

In the pivotal trial comparing PRADAXA to warfarin, the most frequent adverse reactions leading to discontinuation of PRADAXA were bleeding and gastrointestinal events. PRADAXA 150 mg resulted in a higher rate of major gastrointestinal (GI) bleeds and any GI bleeds compared to warfarin. In patients greater than or equal to 75 years of age, the risk of major bleeding may be greater with PRADAXA than with warfarin. Patients on PRADAXA 150 mg had an increased incidence of GI adverse reactions.  These were commonly dyspepsia (including abdominal pain, upper abdominal pain, abdominal discomfort, and epigastric discomfort) and gastritis-like symptoms (including GERD, esophagitis, gastritis, and GI ulcer).  Drug hypersensitivity reactions were reported in <0.1% of patients receiving PRADAXA.

Other Measures Evaluated

The risk of myocardial infarction was numerically greater in patients who received PRADAXA 150 mg than in those who received warfarin.  

For full PRADAXA prescribing information, please visit www.pradaxa.com or contact Boehringer Ingelheim's Drug Information Unit at 1-800-542-6257.

About Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates in 50 countries and more than 41,500 employees. Since it was founded in 188
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
2. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
3. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
5. New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG
6. New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting
7. New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer
8. Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients
9. Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe
10. New Analyses Indicate that Divigel(R) (estradiol gel) 0.1% Is a Valuable Option for Certain Postmenopausal Women With Hot Flashes
11. Results and Additional Analyses From Efficacy and Safety Study of Cortheras Relaxin in Acute Heart Failure to be Presented at Heart Failure Congress 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 20, 2013  Upsher-Smith Laboratories, Inc., a specialty ... treatments for diseases of the central nervous system, ... website, upsher-smith.com . The new site celebrates ... of the company,s mission statement – Advancing Pharmacotherapy, ... around people with a story to tell, a ...
(Date:5/20/2013)... , May 20, 2013 /PRNewswire-iReach/ -- Specific Technologies, ... first study demonstrating detection of pathogenic bacteria, including ... and Bacillus anthracis which feature ... list of potential bio-threats. This seminal study, conducted ... Laboratory, Salisbury (DSTL), ...
(Date:5/20/2013)... -- TRACE International today released its Global Enforcement Report ... individuals and government or business entities for bribery and ... 2012 is the third in an annual series from ... "Although the number of outbound enforcement actions fell last ... said Alexandra Wrage , TRACE Founder ...
Breaking Medicine Technology:Upsher-Smith Introduces Newly Redesigned Corporate Website 2Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria 2TRACE Releases 2012 Global Enforcement Report 2TRACE Releases 2012 Global Enforcement Report 3
... Three Trials FRAZER, Pa., March 17 Cephalon, ... positive results from a phase two clinical trial of ... major depressive disorder in adults with bipolar I disorder. ... by bipolar I disorder, which is characterized by fluctuations ...
... recommendation from the U.S. Preventive Services Task Force (USPSTF) underscores ... and strokes among many adults, the head of Partnership for ... first heart attacks in men and first strokes in women. ... 45 and 79 and to women 55 to 79. ...
Cached Medicine Technology:Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression 2Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression 3Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression 4New Aspirin Recommendation Can Help Prevent Heart Attacks & Strokes, Says Partnership for Prevention 2
(Date:5/21/2013)... Southborough, MA (PRWEB) May 21, 2013 ... a global leader in the development and standardization ... method, jointly developed by Brunswick Laboratories and the ... measuring antioxidants in foods. This decision comes after ... (ERP) chaired by James Harnly of the U.S. ...
(Date:5/21/2013)... Kansas City, MO (PRWEB) May 21, 2013 ... announcing updated news for women who have used the ... patients filing lawsuits alleging blood clot injuries has increased ... those using popular prescription drugs and devices with the ... can find out if others are experiencing similar side ...
(Date:5/21/2013)... Fulton, MD (PRWEB) May 21, 2013 ... don’t often think about. Not only is it more difficult ... down can become tricky. Fortunately, there are a variety of ... extra help. One such product is the raised toilet seat. ... the floor, making it easier to stand back up or ...
(Date:5/20/2013)... CA (PRWEB) May 21, 2013 USA ... A Transcendent Approach to Peak Performance" won the top ... Non-Fiction Category. Chosen over a multitude of international ... global attention and critical acclaim from both mainstream and ... levels - mentally, physically and spiritually. , ...
(Date:5/20/2013)... 2013 Heritage Woods of Gurnee ... County, Illinois, is hosting Breakfast and Bingo at 8:30 ... is located at 3775 Grand Ave. in Gurnee, Illinois, ... Medicaid, who need some help to maintain their independence. ... games of bingo," says Tammy Temaner-Rosas, Director of Marketing ...
Breaking Medicine News(10 mins):Health News:AOAC International Approves ORAC as First Action Official Method 2Health News:DrugRisk Update Shows Increase in NuvaRing Blood Clot Lawsuits 2Health News:JustHomeMedical.com Launches Raised Toilet Seats Category 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 3Health News:Heritage Woods of Gurnee Affordable Assisted Living Community to Host Breakfast and Bingo 2
... The US-China Business,Council (USCBC) today encouraged American ... in China in response to the devastating earthquake,that ... member companies have already pledged several million dollars ... to earthquake victims and many,have established matching funds ...
... release earlier this,year, the FDA issued a Public Health ... and cold products should not,be used to treat infants ... and potentially life-threatening side effects can occur from such,use., ... that OTC cough,and cold medicines not be used for ...
... cholesterol-lowering drugs showed some benefits in preliminary trial ... appear to be associated with a lower risk ... fibrillation in postmenopausal women with coronary disease. , ... atrial fibrillation, but it certainly supports the hypothesis ...
... SAN DIEGO, May 15 - RealAge, Inc., ... Life to the Youngest" and,pursue health and wellness ... Award at the 2008 Pharmaceutical Advertising and Marketing,Excellence ... The,RealAge/ARD Marketing Valtrex(R) campaign was honored in the ...
... HIV/AIDS Fundraising Spectacular Takes Place June 14 & 15 at Paris Las ... ... May 15 It,s an all-original, all-singing,all-dancing musical journey across America when ... production show. The spectacular is staged June 14 and 15 in Le,Theatre ...
... May 15 /PRNewswire-FirstCall/ - SXC Health Solutions, Corp.,("SXC" or ... leading provider of,pharmacy benefits management services, announces that Mark ... CFO, will present at the,FBR Capital Markets 12th Annual ... SXC,s presentation will take place on Thursday, May 29,2008 ...
Cached Medicine News:Health News:US Companies Aid Chinese Earthquake Victims 2Health News:US Companies Aid Chinese Earthquake Victims 3Health News:US Companies Aid Chinese Earthquake Victims 4Health News:US Companies Aid Chinese Earthquake Victims 5Health News:US Companies Aid Chinese Earthquake Victims 6Health News:US Companies Aid Chinese Earthquake Victims 7Health News:Saline is Safe Alternative to Harmful Cough and Cold Products 2Health News:Statins May Help Older Women Control Irregular Heartbeat 2Health News:RealAge Wins Silver PhAME Award 2Health News:Golden Rainbow Takes a Musical Journey for Its 22nd Annual 'Ribbon of Life' Production Show 2
Used to introduce balloon, electrode, closed or non-tapered end catheters and other devices for intervention....
Used to introduce balloon, diagnostic and guiding catheters, or other devices for intervention....
Used to introduce large balloon, closed and non-tapered end catheters or other devices for intervention....
Used for the introduction of catheters, balloons and other vascular devices....
Medicine Products: